ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED

Company number 10138701

Date	Type	Description	View / Download
29 Oct 2024	AP01	Appointment of Mr. Adam Brent Deutsch as a director on 20 August 2024	(2 pages)
10 Sep 2024	AA	Audit exemption subsidiary accounts made up to 31 December 2023	(22 pages)
10 Sep 2024	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/23	(48 pages)
10 Sep 2024	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/23	(2 pages)
10 Sep 2024	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/23	(1 page)
25 Apr 2024	CS01	Confirmation statement made on 20 April 2024 with no updates	(3 pages)
23 Apr 2024	CH01	Director's details changed for Mr Joshua Hollis Korth on 14 December 2021	(2 pages)
22 Apr 2024	PSC05	Change of details for Envision Pharma Bidco Limited as a person with significant control on 21 April 2016	(2 pages)
27 Sep 2023	AP01	Appointment of Mr Howard Collins Miller Iii as a director on 12 September 2023	(2 pages)
26 Sep 2023	TM01	Termination of appointment of Margaret Heim as a director on 2 August 2023	(1 page)
26 Sep 2023	AA	Audit exemption subsidiary accounts made up to 31 December 2022	(22 pages)
26 Sep 2023	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/22	(58 pages)
26 Sep 2023	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/22	(1 page)
26 Sep 2023	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/22	(2 pages)
26 Apr 2023	CS01	Confirmation statement made on 20 April 2023 with updates	(5 pages)
22 Mar 2023	AP01	Appointment of Mrs Margaret Heim as a director on 21 February 2023	(2 pages)
24 Feb 2023	SH01	Statement of capital following an allotment of shares on 6 February 2023 USD 262,766,211.7	(3 pages)
21 Sep 2022	AA	Audit exemption subsidiary accounts made up to 31 December 2021	(23 pages)
21 Sep 2022	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/21	(61 pages)
21 Sep 2022	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/21	(1 page)
21 Sep 2022	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/21	(3 pages)
27 Jun 2022	AD03	Register(s) moved to registered inspection location 12 New Fetter Lane London EC4A 1JP	(1 page)
27 Jun 2022	AD02	Register inspection address has been changed from Belmont House Station Way Crawley RH10 1JA England to 12 New Fetter Lane London EC4A 1JP	(1 page)
27 Apr 2022	CS01	Confirmation statement made on 20 April 2022 with updates	(5 pages)
26 Apr 2022	SH01	Statement of capital following an allotment of shares on 30 June 2021 USD 262,766,211.66	(3 pages)